Envestnet Asset Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
NFT
ACM
EAM
AP
HP
SCS
Envestnet Asset Management's ABVX Position: Q2 2026 in Review
Envestnet Asset Management increased its Abivax (ABVX) stake by 7% in Q2 2026, buying an estimated $469K and bringing the position to 63,354 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.
Envestnet Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Envestnet Asset Management held 63,354 shares of Abivax worth $8.44M as of Q2 2026.
- Envestnet Asset Management bought 4,145 Abivax shares in Q2 2026, an estimated $469K.
- Abivax made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2053 holding.
- Envestnet Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
- 75 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.